Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
VB

WKN: A2PH5Q | ISIN: KYG9390W1015 | Ticker: VB0
Frankfurt
18.11.26 | 08:06
0,132 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
VIVA BIOTECH HOLDINGS Chart 1 Jahr
5-Tage-Chart
VIVA BIOTECH HOLDINGS 5-Tage-Chart
RealtimeGeldBriefZeit
0,1300,14118.11.

Aktuelle News zur VIVA BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
VIVA BIOTECH Aktie jetzt für 0€ handeln
22.09.VIVA BIOTECH (01873): INTERIM REPORT 20263
26.08.Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth333Results Highlights for Interim Results ended 30 June 2026Revenue reached RMB1,006.5 million, increasing by 21.0% YoYGross profit amounted to RMB341.7 million, increasing...
► Artikel lesen
26.08.Viva Biotech Holdings Announces Decline In H1 Profit1
26.08.VIVA BIOTECH (01873): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 20261
14.08.VIVA BIOTECH (01873): DATE OF BOARD MEETING2
14.07.VIVA BIOTECH (01873): NEXT DAY DISCLOSURE RETURN2
26.06.VIVA BIOTECH (01873): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 26, 20261
25.06.VIVA BIOTECH (01873): VOLUNTARY ANNOUNCEMENT GRANT OF RESTRICTED SHARE UNITS-
25.06.VIVA BIOTECH (01873): NEXT DAY DISCLOSURE RETURN1
18.06.VIVA BIOTECH (01873): NEXT DAY DISCLOSURE RETURN1
10.06.VIVA BIOTECH (01873): NEXT DAY DISCLOSURE RETURN2
03.06.VIVA BIOTECH (01873): NEXT DAY DISCLOSURE RETURN1
27.05.Viva Biotech: From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery865SHANGHAI, May 27, 2026 /PRNewswire/ -- On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, "Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated...
► Artikel lesen
26.05.VIVA BIOTECH (01873): NEXT DAY DISCLOSURE RETURN-
17.03.Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA786SHANGHAI, March 17, 2026 /PRNewswire/ -- Monday, March 16th at 1:30 PM PT, Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting...
► Artikel lesen
29.12.25Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities652SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader...
► Artikel lesen
15.12.25Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.569STOCKHOLM, Dec. 15, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (STO: SOBI) recently announced that it has entered into an acquisition agreement with Arthrosi Therapeutics, Inc., which...
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1